Two lawmakers with personal ties to Alzheimer's disease are urging Congress to pass bipartisan legislation that would mandate Medicare coverage for early blood tests for the condition and related dementias. The push came during a Wednesday event hosted by The Hill and sponsored by HealthyWomen.

Sen. Kevin Cramer (R-N.D.) and Rep. Nanette Barragán (D-Calif.) both backed the Alzheimer's Screening and Prevention (ASAP) Act, which was introduced last year by Sen. Susan Collins (R-Maine). The bill would direct the Centers for Medicare and Medicaid Services (CMS) to cover blood tests for early detection that have been approved by the Food and Drug Administration (FDA).

Read also
Healthcare
Chronic Loneliness in Seniors Linked to 38% Higher Dementia Risk
A University of Bordeaux study links chronic loneliness to a 38% higher dementia risk in seniors, even when living with others. Meaningful connections matter more than proximity.

Cramer, whose mother suffered from Alzheimer's, said in a pre-recorded interview that early diagnosis is crucial for treatment and preparation. "Early diagnosis is better for treatment, for preparation, certainly even for possible cures," he said. "We'll get there hopefully soon and well with Alzheimer's."

The North Dakota Republican also made a fiscal argument for the measure, describing it as a "prudent early investment" that could reduce long-term costs associated with nursing care and in-home services. "This is a prudent early investment that can save lots of money in the long run, whether it's for nursing care to include in home or immersion home, just the preparation for families," Cramer said. "I think there's a message that cuts across the broadest of political swaths."

Barragán, a member of the House Energy and Commerce Health Subcommittee, echoed the need for Medicare to cover these tests. "Without having a Medicare cover and pay for this, it will be inaccessible to some folks," she said in a pre-recorded interview with The Hill's Kathleen Koch. She highlighted that the ASAP Act would also allow CMS to cover future FDA-approved blood tests, calling that provision a "game changer."

The California Democrat also shared her own caregiving experience after her mother was diagnosed with Alzheimer's. "It took way too long for somebody to see if she had the symptoms and she was really at risk for Alzheimer's, and so that's one of the reasons I'm so excited when I hear about new developments, new tests and making sure everybody has access to new tests, because we should know as early as possible," Barragán said.

The legislation has drawn attention as part of a broader push to improve early detection and intervention for Alzheimer's, which affects millions of Americans and costs billions in healthcare and caregiving expenses. Supporters argue that covering these tests under Medicare could lead to earlier treatment and better outcomes for patients and families.

The ASAP Act is one of several recent efforts in Congress to address Alzheimer's and dementia care. Lawmakers have also been looking at broader Medicare coverage for Alzheimer's diagnostics and other health policy changes. The push comes as Democrats are also weighing Medicare expansion proposals in their agenda.

Advocacy groups and patient organizations have voiced support for the ASAP Act, saying it could reduce disparities in access to early detection tools. The bill's sponsors hope to move it through both chambers in the coming months, though no committee votes have been scheduled yet.